Trade in substandard and falsified medicines
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...
Những tác giả chính: | Hagen, N, Hauk, C, Heide, L |
---|---|
Tác giả khác: | Brombacher, D |
Định dạng: | Book section |
Ngôn ngữ: | English |
Được phát hành: |
Nomos
2022
|
Những quyển sách tương tự
-
Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
Bằng: Hauk, C, et al.
Được phát hành: (2021) -
Substandard and Falsified Medicines in Myanmar
Bằng: Mirai Sakuda, et al.
Được phát hành: (2020-03-01) -
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
Bằng: Cavany, S, et al.
Được phát hành: (2023) -
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
Bằng: Sean Cavany, et al.
Được phát hành: (2023-10-01) -
How to achieve international action on falsified and substandard medicines.
Bằng: Attaran, A, et al.
Được phát hành: (2012)